Athira Pharma (ATHA)
(Delayed Data from NSDQ)
$3.30 USD
-0.07 (-2.08%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $3.32 +0.02 (0.61%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.75 |
EPS Last Quarter | -0.69 |
Last EPS Surprise | 13.75% |
ABR | 1.80 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.79 |
Next Year | -3.46 |
EPS (TTM) | -3.05 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.75 | -0.78 | -2.79 | -3.46 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.75 | -0.77 | -2.59 | -3.38 |
Low Estimate | -0.75 | -0.78 | -2.99 | -3.53 |
Year ago EPS | -0.78 | -0.87 | -3.09 | -2.79 |
Year over Year Growth Est. | 3.85% | 10.34% | 9.71% | -23.84% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.75 | -0.78 | -2.79 | -3.46 |
7 Days Ago | -0.75 | -0.78 | -2.79 | -3.46 |
30 Days Ago | -0.75 | -0.78 | -2.79 | -3.46 |
60 Days Ago | -0.75 | -0.78 | -2.79 | -3.46 |
90 Days Ago | -0.80 | -0.80 | -2.86 | -3.00 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.75 | -0.78 | -2.79 | -3.46 |
Zacks Consensus Estimate | -0.75 | -0.78 | -2.79 | -3.46 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.69 | -0.71 | -0.87 | -0.78 | NA |
Estimate | -0.80 | -0.96 | -0.87 | -0.81 | NA |
Difference | 0.11 | 0.25 | 0.00 | 0.03 | 0.10 |
Surprise | 13.75% | 26.04% | 0.00% | 3.70% | 10.87% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more